Advertisement

Renogenic characterization and in vitro differentiation of rat amniotic fluid stem cells into renal proximal tubular- and juxtaglomerular-like cells

  • Ekta Minocha
  • Chandra Prakash Chaturvedi
  • Soniya NityanandEmail author
Article
  • 49 Downloads

Abstract

The aim of the present study was to investigate the renogenic characteristics of amniotic fluid stem cells (AFSCs) and to evaluate their in vitro differentiation potential into renal proximal tubular-like cells and juxtaglomerular-like cells. We culture expanded AFSCs derived from rat amniotic fluid. The AFSCs grew as adherent spindle-shaped cells and expressed mesenchymal markers CD73, CD90, and CD105 as well as renal progenitor markers WT1, PAX2, SIX2, SALL1, and CITED1. AFSCs exhibited an in vitro differentiation potential into renal proximal tubular epithelial-like cells, as shown by the upregulation of expression of proximal tubular cell–specific genes like AQP1, CD13, PEPT1, GLUT5, OAT1, and OCT1. AFSCs could also be differentiated into juxtaglomerular-like cells as demonstrated by the expression of renin and α-SMA. The AFSCs also expressed pluripotency markers OCT4, NANOG, and SOX2 and could be induced into embryoid bodies with differentiation into all the three germ layers, highlighting the pluripotent nature of these cells. Our results show that amniotic fluid contains a population of primitive stem cells that express renal-progenitor markers and also possess the propensity to differentiate into two renal lineage cell types and, thus, may have a therapeutic potential in renal regenerative medicine.

Keywords

Amniotic fluid stem cells Renal progenitor markers Proximal tubular epithelial cells Juxtaglomerular cells Embryoid bodies 

Notes

Acknowledgement

The authors would like to extend their sincere thanks to Miss Manali Jain and Miss Shobhita Katiyar for assisting them in performing the growth kinetics and flow cytometry experiments. We would also like to express our gratitude to Dr. Anup Kumar, Assistant Professor, Department of Biostatistics, SGPGIMS, for extending his help for statistical analysis.

Funding information

This work was supported by an Extramural Grant (BT/PR16863/MED/31/338/2016) of the Department of Biotechnology (DBT), Govt. of India, sanctioned to SN and Wellcome Trust DBT India Alliance Fellowship Grant (IA/I/16/1/502374) sanctioned to CPC. EM is the recipient of the Department of Science and Technology (DST), Govt. of India, INSPIRE PhD fellowship.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

References

  1. Antonucci I, Di Pietro R, Alfonsi M, Centurione MA, Centurione L, Sancilio S, Pelagatti F, D’Amico MA, Di Baldassarre A, Piattelli A, Tete S, Palka G, Borlongan CV, Stuppia L (2014) Human second trimester amniotic fluid cells are able to create embryoid body-like structures in vitro and to show typical expression profiles of embryonic and primordial germ cells. Cell Transplant. 23:1501–1515CrossRefGoogle Scholar
  2. Basta JM, Robbins L, Kiefer SM, Dorsett D, Rauchman M (2014) Sall1 balances self-renewal and differentiation of renal progenitor cells. Development 141:1047–1058CrossRefGoogle Scholar
  3. Brunskill EW, Sequeira-Lopez MLS, Pentz ES, Lin E, Yu J, Aronow BJ, Potter SS, Gomez RA (2011) Genes that confer the identity of the renin cell. J. Am. Soc. Nephrol. 22:2213–2225CrossRefGoogle Scholar
  4. Cananzi M, De Coppi P (2012) CD117(+) amniotic fluid stem cells: state of the art and future perspectives. Organogenesis 8:77–88CrossRefGoogle Scholar
  5. Da Monteiro Carvalho Mori Cunha MG, Zia S, Arcolino FO, Carlon MS, Beckmann DV, Pippi NL, Graça DL, Levtchenko E, Deprest J, Toelen J (2015) Amniotic fluid derived stem cells with a renal progenitor phenotype inhibit interstitial fibrosis in renal ischemia and reperfusion injury in rats. PLoS One 10:1–21CrossRefGoogle Scholar
  6. Da Sacco S, Sedrakyan S, Boldrin F, Giuliani S, Parnigotto P, Habibian R, Warburton D, De Filippo RE, Perin L (2010) Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J. Urol. 183:1193–1200CrossRefGoogle Scholar
  7. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, Bonhomme D, Ezine S, Frydman R, Cavazzana-Calvo M (2009) Human and murine amniotic fluid c-Kit+ Lin- cells display hematopoietic activity. Blood 113:3953–3960CrossRefGoogle Scholar
  8. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317CrossRefGoogle Scholar
  9. Frey IM, Rubio-Aliaga I, Siewert A, Sailer D, Drobyshev A, Beckers J, de Angelis MH, Aubert J, Bar Hen A, Fiehn O, Eichinger HM, Daniel H (2007) Profiling at mRNA, protein, and metabolite levels reveals alterations in renal amino acid handling and glutathione metabolism in kidney tissue of Pept2-/-mice. Physiol. Genomics 28:301–310CrossRefGoogle Scholar
  10. Fukuzawa T, Fukazawa M, Ueda O, Shimada H, Kito A, Kakefuda M, Kawase Y, Wada NA, Goto C, Fukushima N, Jishage K-I, Honda K, King GL, Kawabe Y (2013) SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose. PLoS One 8:e56681CrossRefGoogle Scholar
  11. Gupta AK, Jadhav SH, Tripathy NK, Nityanand S (2015a) Fetal Kidney cells can ameliorate ischemic acute renal failure in rats through their anti-inflammatory, anti-apoptotic and anti-oxidative effects. PLoS One 10:e0131057CrossRefGoogle Scholar
  12. Gupta AK, Jadhav SH, Tripathy NK, Nityanand S (2015b) Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis. World J. Stem Cells 7:776–788CrossRefGoogle Scholar
  13. Jin W, Penington CJ, McCue SW, Simpson MJ (2017) A computational modelling framework to quantify the effects of passaging cell lines. PLoS One 12:e0181941CrossRefGoogle Scholar
  14. Kang M, Han Y-M (2014) Differentiation of human pluripotent stem cells into nephron progenitor cells in a serum and feeder free system. PLoS One 9:e94888CrossRefGoogle Scholar
  15. Krause M, Rak-Raszewska A, Pietila I, Quaggin SE, Vainio S (2015) Signaling during kidney development. Cells 4:112–132CrossRefGoogle Scholar
  16. Li Y, Jalili RB, Ghahary A (2016) Accelerating skin wound healing by M-CSF through generating SSEA-1 and -3 stem cells in the injured sites. Sci. Rep. 6:28979CrossRefGoogle Scholar
  17. Lu Y, Wang Z, Chen L, Wang J, Li S, Liu C, Sun D (2018) The in vitro differentiation of GDNF gene-engineered amniotic fluid-derived stem cells into renal tubular epithelial-like cells. Stem Cells Dev. 27(9):590–599CrossRefGoogle Scholar
  18. Marcus AJ, Woodbury D (2008) Fetal stem cells from extra-embryonic tissues: do not discard. J. Cell. Mol. Med. 12:730–742CrossRefGoogle Scholar
  19. Matsushita K, Morello F, Wu Y, Zhang L, Iwanaga S, Pratt RE, Dzau VJ (2010) Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. J. Biol. Chem. 285:11974–11982CrossRefGoogle Scholar
  20. Mu D, Zhang X-L, Xie J, Yuan H-H, Wang K, Huang W, Li G-N, Lu J-R, Mao L-J, Wang L, Cheng L, Mai X-L, Yang J, Tian C-S, Kang L-N, Gu R, Zhu B, Xu B (2016) Intracoronary transplantation of mesenchymal stem cells with overexpressed integrin-linked kinase improves cardiac function in porcine myocardial infarction. Sci. Rep. 6:19155CrossRefGoogle Scholar
  21. Murphy AJ, Pierce J, de Caestecker C, Taylor C, Anderson JR, Perantoni AO, de Caestecker MP, Lovvorn HN III (2012) SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms’ tumor. J. Pediatr. Surg. 47:1239–1249CrossRefGoogle Scholar
  22. Narayanan K, Schumacher KM, Tasnim F, Kandasamy K, Schumacher A, Ni M, Gao S, Gopalan B, Zink D, Ying JY (2013) Human embryonic stem cells differentiate into functional renal proximal tubular-like cells. Kidney Int. 83:593–603CrossRefGoogle Scholar
  23. Noronha IL, Cavaglieri RC, Janz FL, S a D, Lopes M a B, Zugaib M, Bydlowski SP (2011) The potential use of stem cells derived from human amniotic fluid in renal diseases. Kidney Int. Suppl. 1:77–82CrossRefGoogle Scholar
  24. Peired AJ, Sisti A, Romagnani P (2016) Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence. Stem Cells Int. 2016:4798639Google Scholar
  25. Persson PB (2003) Renin: origin, secretion and synthesis. J. Physiol. 552:667–671CrossRefGoogle Scholar
  26. Pfaller W, Gstraunthaler G (1998) Nephrotoxicity testing in vitro--what we know and what we need to know. Environ. Health Perspect. 106(Suppl):559–569Google Scholar
  27. Siegel N, Rosner M, Hanneder M, Valli A, Hengstschläger M (2007) Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev. 3:256–264CrossRefGoogle Scholar
  28. Underwood MA, Gilbert WM, Sherman MP (2005) Amniotic fluid: not just fetal urine anymore. J. Perinatol. 25:341–348CrossRefGoogle Scholar

Copyright information

© The Society for In Vitro Biology 2019

Authors and Affiliations

  1. 1.Stem Cell Research Facility, Department of HematologySanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS)LucknowIndia

Personalised recommendations